Products and Services
-
DPI developer Iconovo has announced that a PK study of its ICOres reservoir-based inhaler demonstrated that the device delivered a budesonide/formoterol dry powder formulation as expected compared to Symbicort Turbuhaler. According to the company, the… Read more . . .
-
Kurve Technology has announced that Seurat Therapeutics will use Kurve’s intranasal delivery technology for Seurat’s IGF-1 nasal aerosol for the treatment and prevention of migraines. Details of the development and collaboration agreement were not disclosed.… Read more . . .
-
Proveris Scientific announced that Stephen McDonald has joined the company’s European team, which is based in the UK. McDonald, who has previously worked with Proveris to provide customer support as an independent contractor, will work… Read more . . .
-
AptarGroup has announced its acquisition of Nanopharm and Gateway Analytical as “part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.”… Read more . . .
-
Windtree Therapeutics and Eleison Pharmaceuticals have announced results from a study that demonstrated the feasibility of delivering Eleison’s inhaled lipid cisplatin (ILC) via Windtree’s Aerosol Delivery System (ADS). In March 2018, the companies announced that… Read more . . .
-
Clement Clarke has announced the launch of its Clip-Tone technique guidance whistle for use with GSK’s Evohaler Ventolin and Seretide MDIs in the UK. The Clip-Tone will be available by prescription only. Like the company’s… Read more . . .
-
CDMO Particle Sciences is now registered with the US Drug Enforcement Administration (DEA) as a manufacturer of Schedule I substances, which means that the company can now provide development and manufacturing services for pharmaceutical cannabinoid… Read more . . .
-
Proveris Scientific has announced the availability of new testing services that “support the FDA’s newly released draft guidance on beclomethasone dipropionate that promotes alternate in-vitro studies in lieu of clinical endpoint.” According to Proveris, the… Read more . . .
-
Inhalation Sciences (ISAB) has announced that it will divest 40,000 shares of its subsidiary Ziccum AB in order to finance a study to validate its PreciseInhale dosing system for clinical use. The company said that… Read more . . .
-
KAER Biotherapeutics gets SBIR grant for development of aerosol therapy for RDS in premature infants
KAER Biotherapeutics has received a $300,000 Small Business Innovation Research (SBIR) grant from the National Heart Lung and Blood Institute of the National Institutes of Health for preclinical development of its SUPRAER aerosol platform for… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland